Table 1.
lncRNA HOXA-AS3 expression and clinical characteristics in human diseases and pathophysiological processes
| Disease type | Expression | Clinical characteristics | Refs |
|---|---|---|---|
| Liver cancer | Overexpression | Overall survival | [23–25] |
| Glioma | Overexpression | Overall survival and pathological grade | [26, 27] |
| Lung cancer | Overexpression | – | [28–30] |
| Oral cancer | Overexpression | Pathological stage, and overall survival | [31] |
| Colorectal cancer | Overexpression | – | [32] |
| Gastric cancer | Overexpression | Tumor size, lymph node status, invasion depth, Helicobacter pylori infection status, over survival, and disease-free survival | [33] |
| Pancreatic cancer | Overexpression | Poor prognosis, TNM stage, and lymph node metastasis | [34] |
| Atherosclerosis | Overexpression | Pathological conditions of the coronary wall, the levels of TG, TC, and LDL-C | [36, 37] |
| Pulmonary arterial hypertension | Overexpression | – | [38] |
| MSCs lineage determination | Overexpression | – | [39] |